DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS
The invention relates to compounds of formula (I) inhibiting Rho Kinase that are dihydrofuropyridine derivatives, methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. Particularly the compounds of the invention may be useful in the treatment of many disorders associated with ROCK enzymes mechanisms, such as pulmonary diseases including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH)..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 25. Okt. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
RANCATI FABIO [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-10-25, Last update posted on www.tib.eu: 2023-11-07, Last updated: 2023-11-10 |
|---|
| Patentnummer: |
EP4263547 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018330436 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018330436 | ||
| 003 | DE-627 | ||
| 005 | 20231110091022.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231103s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018330436 | ||
| 035 | |a (EPA)EP4263547 | ||
| 035 | |a (EPA)73854549 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a RANCATI FABIO |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a DIHYDROFUROPYRIDINE DERIVATIVES AS RHO- KINASE INHIBITORS |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-10-25, Last update posted on www.tib.eu: 2023-11-07, Last updated: 2023-11-10 | ||
| 520 | |a The invention relates to compounds of formula (I) inhibiting Rho Kinase that are dihydrofuropyridine derivatives, methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. Particularly the compounds of the invention may be useful in the treatment of many disorders associated with ROCK enzymes mechanisms, such as pulmonary diseases including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH). | ||
| 650 | 4 | |a C07D: Heterocyclic compounds (macromolecular compounds c08) | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a ACCETTA ALESSANDRO |4 aut | |
| 700 | 0 | |a CAPELLI ANNA MARIA |4 aut | |
| 700 | 0 | |a PALA DANIELE |4 aut | |
| 700 | 0 | |a MAZZUCATO ROBERTA |4 aut | |
| 700 | 0 | |a EDWARDS CHRISTINE |4 aut | |
| 700 | 0 | |a PASQUA ADELE ELISA |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 25. Okt. |
| 773 | 1 | 8 | |g year:2023 |g day:25 |g month:10 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/73854549/publication/EP4263547A1?q=EP4263547 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 25 |c 10 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 25 |c 10 | ||